"The head-to-head comparison ... presents a significant opportunity to continue demonstrating the superior diagnostic capabilities of our ... platforms"
...is surely the verbalisation of, wink wink, nudge, nudge.
But on the flip side, it's only a minor medical thing, if you were signing up for diagnstics or treatments don;t you want to know you are getting the best available.
Some before me have noted that H2H trials are a rarity.
This to me adds to the impressive stature of Alan Taylor in that he displays the professional and person ethics to find a better, and the best, way to deal with a condition close to his heart and is prepared to put his money where his mouth is, especially just 48 hours before the AGM.
CU6 Price at posting:
$6.47 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)